Volume Spike Investor

XOMA Ltd. (NASDAQ: XOMA) is surging this morning after a late-day run on Thursday. On Thursday, Xoma announced that its bacterial cell expression (BCE) technology licensee UCB S.A. has received FDA approval to market CIMZIA(r) for the treatment of moderate to severe rheumatoid arthritis in adults. XOMA will receive royalty payments on sales of CIMZIA [...]

Exelixis, Inc. (NASDAQ: EXEL) is trading up sharply early this morning on word from last night’s ASCO abstract that that its cancer study was very promising for brain cancer patients.  Shares were up 35% last night at the after-hours peak in thin volume, and this morning we have shares indicated up almost 23% at $5.55 [...]